MedTrace Logo

HD-tDCs to Improve Upper Extremity Function in Patients With Acute Middle Cerebral Artery Stroke

NCT04000269 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-03-31

No results posted yet for this study

Summary

To determine if using targeted high definition transcranial direct current stimulation can improve upper extremity motor function in patients with subacute middle cerebral artery (MCA) stroke.

Conditions

  • Middle Cerebral Artery Stroke

Interventions

DEVICE

Soterix MxN Neuromodulation device

Up to 2 mA stimulation to primary motor cortex for 10 sessions at 20min per session

DEVICE

Sham Stimulation

Uses slight stimulation initially then turns of and provides no stimulation after a few seconds.

Sponsors & Collaborators

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • William A Pomilla, MD · Assistant Professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-05
Primary Completion
2022-09-05
Completion
2022-09-05

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04000269 on ClinicalTrials.gov